[
  {
    "ref_criterion": "Provides individual answers for both the management of heart failure and T2DM in the context of optimizing fluid status and cardiovascular outcomes, emphasizing medications that have a dual effect on both HF and T2DM, such as SGLT2 inhibitors and increasingly, GLP-1 agonists.",
    "ref_axis": "completeness",
    "ref_point": 7,
    "gen_criterion": "Correctly recommends SGLT2 inhibitors for patients with stable heart failure and type 2 diabetes.",
    "gen_axis": "accuracy",
    "gen_point": 9,
    "similarity": 0.6774,
    "point_diff": 2,
    "score": 0.677,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Recommends maximizing GDMT therapy as tolerated, specifying that blood pressure is usually the limiting factor, for HFrEF given its mortality benefit.",
    "ref_axis": "accuracy",
    "ref_point": 6,
    "gen_criterion": "Does not mention the potential benefits of GLP-1 receptor agonists for patients with type 2 diabetes and stable heart failure.",
    "gen_axis": "completeness",
    "gen_point": -2,
    "similarity": 0.4055,
    "point_diff": 8,
    "score": 0.0,
    "similar_match": false,
    "axis_match": false
  },
  {
    "ref_criterion": "Does not lay out each of the four GDMT pillars for the user (beta blockade, ACE/ARB/ARNI, MRA, SGLT2i).",
    "ref_axis": "completeness",
    "ref_point": -5,
    "gen_criterion": "Does not provide alternative medication options for patients who are not tolerant of SGLT2 inhibitors.",
    "gen_axis": "completeness",
    "gen_point": -4,
    "similarity": 0.2832,
    "point_diff": 1,
    "score": 0.283,
    "similar_match": false,
    "axis_match": true
  },
  {
    "ref_criterion": "Correctly classifies the patient as having heart failure with mildly reduced ejection fraction (HFmrEF). (Justification: This is by virtue of the ejection fraction being 45. HFmrEF refers to a patient with an ejection fraction between 40-49%.)",
    "ref_axis": "accuracy",
    "ref_point": 5,
    "gen_criterion": "Does not provide information about the importance of monitoring for ejection fraction levels in patients with stable heart failure.",
    "gen_axis": "completeness",
    "gen_point": -2,
    "similarity": 0.6514,
    "point_diff": 7,
    "score": 0.0,
    "similar_match": true,
    "axis_match": false
  },
  {
    "ref_criterion": "Does not suggest lifestyle modifications such as dietary sodium restriction to a maximum of 2g to help with fluid retention. (Justification: This helps avoid fluid retention since sodium retains free water in the body.)",
    "ref_axis": "completeness",
    "ref_point": -5,
    "gen_criterion": "Does not provide information about the importance of monitoring for mild fluid retention when using GLP-1 receptor agonists.",
    "gen_axis": "completeness",
    "gen_point": -1,
    "similarity": 0.4943,
    "point_diff": 4,
    "score": 0.395,
    "similar_match": false,
    "axis_match": true
  },
  {
    "ref_criterion": "Suggests a trial of a low dose diuretic, such as Lasix 20mg, in a diuretic-naive patient for a couple of days, as this causes diuresis and treats mild edema.",
    "ref_axis": "accuracy",
    "ref_point": 6,
    "gen_criterion": "Does not mention the potential risks or side effects of medications.",
    "gen_axis": "completeness",
    "gen_point": -5,
    "similarity": 0.3398,
    "point_diff": 11,
    "score": 0.0,
    "similar_match": false,
    "axis_match": false
  },
  {
    "ref_criterion": "Correctly recommends the addition of an SGLT2 inhibitor such as Dapagliflozin and Empagliflozin, which is beneficial as a heart failure medication (reduces cardiovascular mortality and hospitalization) and as a diabetic drug (helps reduce the HbA1C by about 0.8).",
    "ref_axis": "accuracy",
    "ref_point": 8,
    "gen_criterion": "Correctly recommends SGLT2 inhibitors for patients with stable heart failure and type 2 diabetes.",
    "gen_axis": "accuracy",
    "gen_point": 9,
    "similarity": 0.761,
    "point_diff": 1,
    "score": 0.761,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "Correctly mentions that SGLT2 inhibitors have a class 1 indication in HFmrEF per the 2023 focused update of the ESC heart failure guidelines.",
    "ref_axis": "accuracy",
    "ref_point": 5,
    "gen_criterion": "Correctly recommends SGLT2 inhibitors for patients with stable heart failure and type 2 diabetes.",
    "gen_axis": "accuracy",
    "gen_point": 9,
    "similarity": 0.6938,
    "point_diff": 4,
    "score": 0.555,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "Mentions guideline-directed optimal medical therapy for HF & DM, including SGLT2 inhibitor, optimized ARNI, BB, MRA, and diuretic when fluid overloaded, and suggests that a GLP agonist might be considered if SGLT2 inhibitor is not tolerated for good CVS outcomes.",
    "ref_axis": "accuracy",
    "ref_point": 10,
    "gen_criterion": "Correctly recommends GLP-1 receptor agonists as an alternative for patients who are not tolerant of SGLT2 inhibitors.",
    "gen_axis": "accuracy",
    "gen_point": 8,
    "similarity": 0.6351,
    "point_diff": 2,
    "score": 0.635,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "Describes optimal guideline-directed medical therapy for stable HF-EF 45% and DM, prioritizing SGLT2 inhibitors over ARNI/ACEI, BB, and MRA, and optimizing diabetic care.",
    "ref_axis": "accuracy",
    "ref_point": 8,
    "gen_criterion": "Correctly recommends SGLT2 inhibitors for patients with stable heart failure and type 2 diabetes.",
    "gen_axis": "accuracy",
    "gen_point": 9,
    "similarity": 0.6601,
    "point_diff": 1,
    "score": 0.66,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "Justifies the cardiovascular benefits of SGLT2 inhibitors and GLP agonists, describes the pharmacologic treatment of stable heart failure (ACEI/ARB, BB, MRA), and optimizes glycemic control for better cardiovascular outcomes. (Justification: Cardiovascular outcomes are not mainly affected by tight glycemic control, even though microvascular complications are reduced.)",
    "ref_axis": "accuracy",
    "ref_point": -8,
    "gen_criterion": "Correctly recommends SGLT2 inhibitors for patients with stable heart failure and type 2 diabetes.",
    "gen_axis": "accuracy",
    "gen_point": 9,
    "similarity": 0.8027,
    "point_diff": 17,
    "score": 0.0,
    "similar_match": true,
    "axis_match": true
  },
  {
    "ref_criterion": "The response must be entirely factually accurate---that is, all sentences in the response must be medically factual. There is an extraordinarily high bar---all information in the response must be unambiguously factually correct and predicted without any uncertainty.\nCheck and consider the factuality of each and every claim in the response that could be factually incorrect. Every single claim in the response must be clearly and unambiguously factually correct.\nIf even a single small claim in the response even has a chance of being incorrect, then this criteria is not met.\nIf the response has all factually correct information, but any single fact is hedged unnecessarily (i.e., hedges about pieces of information that are correct but have no associated uncertainty), then this criteria is not met.\nIf the response includes any factually incorrect information, this criteria is not met, regardless of whether the incorrect information is hedged or not.",
    "ref_axis": "accuracy",
    "ref_point": 5,
    "gen_criterion": "Provides a clear and concise summary of the patient's condition, medication plan, and potential concerns, and uses natural language and correct interpretation in the response.",
    "gen_axis": "communication_quality",
    "gen_point": 9,
    "similarity": 0.431,
    "point_diff": 4,
    "score": 0.345,
    "similar_match": false,
    "axis_match": false
  },
  {
    "ref_criterion": "Step 1: Is the core question answered clearly and early? If not, fail.\nStep 2: Brainstorm any missing details or caveats. If something is absent, fail.\nStep 3: Check for unnecessary bulk or off-topic content. If present, fail.\nIf all three steps pass, mark criteria_met = true.\nIf any of the steps fail, mark criteria_met = false.",
    "ref_axis": "communication_quality",
    "ref_point": 5,
    "gen_criterion": "Provides a clear and concise summary of the patient's condition, medication plan, and potential concerns, and uses natural language and correct interpretation in the response.",
    "gen_axis": "communication_quality",
    "gen_point": 9,
    "similarity": 0.2028,
    "point_diff": 4,
    "score": 0.162,
    "similar_match": false,
    "axis_match": true
  }
]